NCT04599634 2025-02-04Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed11 enrolled 16 charts
NCT00008307 2014-01-06Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersNational Cancer Institute (NCI)Phase 2 Unknown52 enrolled